Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Curemark to begin tests of drug in autism victims


Curemark LLC, a Rye-based drug research and development company focused on neurological diseases, said that it has received regulatory clearance to start a drug testing program.

The tests, designed to study the effectiveness of Curemark’s CM-AT medication as an autism treatment, are expected to begin the tests at multiple sites across the country during the second quarter.

“With 1 in 150 children diagnosed with autism, we have children who are suffering,” Dr. Joan Fallon, Curemark’s chief executive officer, said in a written statement. “We are very excited about the opportunity to enter a Phase III trial for this ever-growing population of children.”

This entry was posted on Wednesday, March 25th, 2009 at 3:46 pm by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical



About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.


Get blog updates via email:

About the Authors


Other recent entries


Monthly Archives